July 9, 2020 / 4:17 PM / a month ago

BRIEF-CMS Establishes Unique J-Code For Eagle Pharmaceuticals' PEMFEXY

July 9 (Reuters) - Eagle Pharmaceuticals Inc:

* CMS ESTABLISHES UNIQUE J-CODE FOR EAGLE PHARMACEUTICALS’ PEMFEXY (PEMETREXED FOR INJECTION)

* EAGLE PHARMACEUTICALS - RECEIVED SUPPLEMENT APPROVAL FROM FDA FOR 500 MG MULTIPLE-DOSE VIAL OF PEMFEXY ON JUNE 18

* EAGLE PHARMACEUTICALS - CO IS ENTITLED TO INITIAL MARKET ENTRY ON FEB 1, 2022 FOR PEMFEXY

* EAGLE PHARMACEUTICALS INC - CO IS ENTITLED TO SUBSEQUENT UNCAPPED ENTRY ON APRIL 1, 2022 FOR PEMFEXY

* EAGLE PHARMACEUTICALS INC - UNIQUE J-CODE FOR PEMFEXY WILL BECOME EFFECTIVE ON OCTOBER 1 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below